Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Hanekom WA., Dockrell HM., Ottenhoff THM., Doherty TM., Fletcher H., McShane H., Weichold FF., Hoft DF., Parida SK., Fruth UJ.

Willem Hanekom and colleagues make recommendations on assay harmonization for novel tuberculosis vaccine trials.

More information Original publication

DOI

10.1371/journal.pmed.0050145

Type

Journal article

Publication Date

2008-07-01T00:00:00+00:00

Volume

Keywords

Clinical Trials as Topic, Health Planning Guidelines, Humans, Treatment Outcome, Tuberculosis, Tuberculosis Vaccines, World Health Organization